Caxton Corporation’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,036
| Closed | -$50.9K | – | 13 |
|
|
2024
Q4 | $50.9K | Buy |
+2,036
| New | +$50.9K | 0.31% | 13 |
|
|
2020
Q2 | – | Sell |
-151
| Closed | -$34K | – | 19 |
|
|
2020
Q1 | $34K | Sell |
151
-106
| -41% | -$23.9K | 0.04% | 17 |
|
|
2019
Q4 | $136K | Sell |
257
-9
| -3% | -$4.76K | 0.13% | 39 |
|
|
2019
Q3 | $115K | Buy |
+266
| New | +$115K | 0.13% | 38 |
|